Management of cancer‐associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement

BACKGROUND: Optimal management of cancer‐associated thrombosis (CAT) in patients with thrombocytopenia remains difficult given competing risks of recurrent thrombosis and increased bleeding. We determine the impact of the ISTH Scientific and Standardization Committee (SCC) guidance on CAT management...

Descripción completa

Detalles Bibliográficos
Autores principales: Held, Nicole, Jung, Benjamin, Baumann Kreuziger, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133434/
https://www.ncbi.nlm.nih.gov/pubmed/35664532
http://dx.doi.org/10.1002/rth2.12726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133434/
https://www.ncbi.nlm.nih.gov/pubmed/35664532
http://dx.doi.org/10.1002/rth2.12726

Ejemplares similares